Literature DB >> 15021933

[Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality].

K Gardlo1, S Hanneken, T Ruzicka, N J Neumann.   

Abstract

We report about a 19-year-old Turkish patient who presented with cutaneous leishmaniasis after a holiday in Turkey. Cutaneous leishmaniasis often heals spontaneously leading to life-long immunity, but it can persist and lead to extensive scarring. In the literature, many therapeutic modalities have been reported; however, they can be accompanied by severe side effects. In our patient, photodynamic therapy resulted in healing of the lesion with only slight hypopigmentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021933     DOI: 10.1007/s00105-004-0710-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  19 in total

1.  Treatment of cutaneous leishmaniasis with photodynamic therapy.

Authors:  Claes D Enk; Clemens Fritsch; Flory Jonas; Abedelmajeed Nasereddin; Arieh Ingber; Charles L Jaffe; Thomas Ruzicka
Journal:  Arch Dermatol       Date:  2003-04

Review 2.  Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years.

Authors:  J D Berman
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

3.  [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].

Authors:  A C Saldanha; G A Romero; E Merchan-Hamann; A V Magalhães; V de O Macedo
Journal:  Rev Soc Bras Med Trop       Date:  1999 Jul-Aug       Impact factor: 1.581

Review 4.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

5.  Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study.

Authors:  K A Bahamdan; T M Tallab; H Johargi; M M Nourad; K Ibrahim; A H el Sherbini; E Karkashan; A K Khare; M M Nauri
Journal:  Int J Dermatol       Date:  1997-01       Impact factor: 2.736

6.  Clinical diagnosis of cutaneous leishmaniasis (oriental sore).

Authors:  R Kubba; Y Al-Gindan; A M el-Hassan; A H Omer
Journal:  J Am Acad Dermatol       Date:  1987-06       Impact factor: 11.527

7.  Treatment of cutaneous leishmaniasis by photodynamic therapy.

Authors:  Kerstin Gardlo; Zuzana Horska; Claes David Enk; Lucie Rauch; Mossad Megahed; Thomas Ruzicka; Clemens Fritsch
Journal:  J Am Acad Dermatol       Date:  2003-06       Impact factor: 11.527

Review 8.  [Cutaneous leishmaniasis].

Authors:  C D Enk; K Gardlo; M Hochberg; A Ingber; T Ruzicka
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

9.  Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.

Authors:  T R Navin; B A Arana; F E Arana; J D Berman; J F Chajón
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

Review 10.  Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.

Authors:  B L Herwaldt; J D Berman
Journal:  Am J Trop Med Hyg       Date:  1992-03       Impact factor: 2.345

View more
  2 in total

1.  Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.

Authors:  Elena Latorre-Esteves; Oleg E Akilov; Prakash Rai; Stephen M Beverley; Tayyaba Hasan
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

Review 2.  [The leishmaniasis - a parasitel infection as differential diagnosis of malignant tumours of oral mucosa. A case report and review of literature].

Authors:  Andreas Wysluch; Florian Sommerer; Hamid Ramadan; Denys Loeffelbein; Klaus-Dietrich Wolff; Frank Hölzle
Journal:  Mund Kiefer Gesichtschir       Date:  2007-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.